Versigent (NYSE: VGNT) lifts 2026 sales outlook, declares dividend
Versigent PLC reported strong Q2 2026 results, with net sales up 10.8% to $2,444 million and Adjusted EBITDA increasing by 24.8% to $272 million. The company raised and narrowed its full-year 2026 net sales guidance to $9,400-$9,600 million and declared an inaugural quarterly cash …